Anaemia in the patient with renal insufficiency: Documenting the impact and reviewing treatment strategies

Nephrology Dialysis Transplantation

Volumn 14, Issue 2, 1999, Pages 292-295

  Levin, Adeera ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; EDITORIAL; HUMAN; KIDNEY FAILURE; PRIORITY JOURNAL;

ANEMIA; HUMANS; KIDNEY FAILURE, CHRONIC;

EID: 0032896112     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.2.292     Document Type: Editorial

References (21)

1. Madore F, Lowrie E, Brugnara C et al. Anemia in hemodialysis patients: variables affecting this outcome predictor. J Am Soc Nephrol 1997; 8: 1921-1929
2. Foley RN, Parfrey PS, Harnett JD et al. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 1996; 28: 53-61
3. Muirhead N, Bargman J, Burgess E et al. Evidence based recommendations for the clinical use of recombinant human erythropoietin. Am J Kidney Dis 1995; 26: S1-24
4. Levin A, Singer J, Thompson CR et al. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis 1996; 27: 347-354
5. Levin A, Thompson CR, Carlisle EJF et al. Left ventricular mass index growth in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis (in press)
6. Canadian Erythropoietin Study Group. Association between recombinant erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Br Med J 1990; 300: 573-578
7. Powe N, Griffiths R, Watson A et al. Effect of recombinant erythropoietin on hospital admission, readmission, length of stay and costs of dialysis patients. J Am Soc Nephrol 1994; 4: 1455-1465
8. Sheingold S, Churchill D, Muirhead N, Laupaucis A, Label R, Geree R. The impact of recombinant human erythropoietin on medical care costs for hemodialysis patients in Canada. Soc Sci Med 1992; 34(9): 983-991
9. Silberberg J, Racine N, Barre P, Sniderman A. Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin. Can J Cardiol 1990; 6: 1-4
10. Revicki DA, Brown RE, Feeny DH et al. Health related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients. Am J Kidney Dis 1995; 25: 548-554
11. Roth D, Smith RD, Schulman G et al. Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients. Am J Kidney Dis 1994; 24: 777-784
12. Teehan BP, Krantz SB, Stone WA. Double blind placebo controlled study of the therapeutic use of recombinant human erythropoietin for anemia associated with chronic renal failure in predialysis patients. Am J Kidney Dis 1991; 18: 50
13. Portoles J, Torralbo A, Martin P et al. Cardiovascular effects of recombinant human erythropoietin in predialysis patients. Am J Kidney Dis 1997; 29(4): 541-548
14. Teehan B, Sigler MH, Brown JM et al. Hematologic and physiologic studies during correction of anemia with recombinant human erythropoiten in predialysis patients. Transplant Proc 1989; 21: 63-66
15. Hashemi G, Autookesh H. Recombinant human erythropoietin in the treatment of anemia in children. Med J Islam Repub Iran 1997; 11(1): 1-4
16. Garcia DL, Anderson S, Rennke HG, Brenner BM. Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass. Proc Natl Acad Sci USA 1988; 85: 6142-6146
17. Myers BC, Deen WM, Robertson CF, Brenner BC. Dynamics of glomerular ultrafiltration in the rat. VIII. Effects of hematocrit. Circ Res 1975; 36: 425-435
18. Krmar RT, Gretz N, Klare B et al. Renal function in predialysis children with chronic renal failure treated with erythropoietin. Pediatr Nephrol 1997; 11(1): 69-73
19. Kuriyama S, Tomonari H, Yoshida H et al. Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in non-diabetic patients. Nephron 1997; 77(2): 176-185
20. Churchill D. An evidence based approach to earlier initiation of dialysis. Am J Kidney Dis 1997; 30(6): 899-905
21. Silverberg DS, Iaina A, Peer G et al. Intravenous iron supplementation of the treatment of anemia of moderate to severe chronic renal failure in patients not receiving dialysis. Am J Kidney Dis 1996; 27: 234-238